Arab Drug and Chemical Industries will hold ordinary and extraordinary general meetings today, April 15, 2014 to look into ratifying the budget estimate for FY14/15.
The company’s extraordinary general meeting will look into raising issued and paid-in capital by EGP 19.5 million from EGP 40.5 million to EGP 60 million at EGP 10 par value plus issue costs each.

The company had posted EGP 1.8 million net profit before tax in H1-13/14.